Journey Medical Corp
DERM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001867066
No open-market purchases or sales by Journey Medical Corp insiders were filed in the last 90 days; 71 institutions reported holding it in 13F filings for Q2 2026, worth $75.2M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Journey Medical Corp changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Of which not filed for Q4 2025 | Q4 2025 | Change |
|---|---|---|---|---|
| Holders | 68 | 1 | 77 | +10 |
| Shares | 8.69M | 132.9K | 11.0M | +2.46M (+28.8%) |
| Value | $61.9M | $946.3K | $85.0M | +$24.0M (+39.4%) |
1 institution that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (17)
Institutions that held Journey Medical Corp at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| J. Goldman & Co LP | 798,366 | $6.16M | 0.24% |
| Millennium Management LLC | 457,812 | $3.53M | 0.00% |
| Ikarian Capital, LLC | 251,436 | $1.94M | 0.25% |
| SEI Investments Co | 109,351 | $843.1K | 0.00% |
| Boothbay Fund Management, LLC | 67,442 | $520.0K | 0.01% |
| Lazard Asset Management LLC | 62,525 | $482.1K | 0.00% |
| Diametric Capital, LP | 51,683 | $398.5K | 0.11% |
| Colony Group, LLC | 19,710 | $152.0K | 0.00% |
| Marshall Wace, LLP | 19,401 | $149.6K | 0.00% |
| Invesco Ltd. | 16,526 | $127.4K | 0.00% |
| XTX Topco Ltd | 16,396 | $126.4K | 0.00% |
| Jane Street Group, LLC | 13,957 | $107.6K | 0.00% |
| Susquehanna International Group, LLP | 12,249 | $94.4K | 0.00% |
| Deutsche Bank AG | 11,560 | $89.1K | 0.00% |
| Simplex Trading, LLC | 434 | $3.35K | 0.00% |
| Federated Hermes, Inc. | 144 | $1.11K | 0.00% |
| The PNC Financial Services Group, Inc. | 74 | $571 | 0.00% |
Sold out (7)
Institutions that held Journey Medical Corp at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Buckingham Strategic Partners | 20,006 | $179.1K |
| Walleye Capital LLC | 22,554 | $160.6K |
| Kovitz Investment Group Partners, LLC | 21,710 | $154.6K |
| Brighton Jones LLC | 16,842 | $119.9K |
| Kestra Advisory Services, LLC | 10,209 | $72.7K |
| Allegiance Financial Group Advisory Services LLC | 10,000 | $71.2K |
| SRS Capital Advisors, Inc. | 46 | $327 |
Not filed for Q4 2025 yet (1)
Institutions that held Journey Medical Corp at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Sheets Smith Investment Management | 132,904 | $946.3K |